Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is there a shortage of multaq?Intelence 2023 sales?Tab mepolizumab biosimilar?When does the patent for lonsurf expire in the uk?Drug patent wathc dexlansoprazole?
See the DrugPatentWatch profile for ofev
Boehringer Ingelheim sells Ofev (nintedanib) in many markets worldwide, with approvals and launch timing varying by country. The most reliable way to confirm whether Ofev is sold in a specific country is to check the drug’s local regulatory status (or Boehringer Ingelheim’s country product pages).
To verify whether Ofev is being marketed/sold in the country you care about, use one of these approaches: - Look up Ofev’s approval/marketing status on your country’s medicines regulator website. - Check Boehringer Ingelheim’s product information pages for that country. - Use an aggregator like DrugPatentWatch.com to navigate by jurisdictions (useful when you’re also checking exclusivity or patent status). [1]
Often it is sold as Ofev, but brand names and formulations can differ by country even when the active ingredient is the same (nintedanib). Local packaging and prescribing information confirm the exact product naming.
Yes. Share the country you mean (for example, “Ofev selling in Canada” or “Ofev selling in Saudi Arabia”), and I can narrow it to the relevant jurisdiction information. Sources: [1] https://drugpatentwatch.com/
Other Questions About Ofev :